Apeimine methylfolate test group - Taiwan Registration 493b22294697a49a0e4a15bb60fe93d8
Access comprehensive regulatory information for Apeimine methylfolate test group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 493b22294697a49a0e4a15bb60fe93d8 and manufactured by FUJIREBIO DIAGNOSTICS, INC.;; ABBOTT GMBH. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
493b22294697a49a0e4a15bb60fe93d8
DHA05603313002
Product Details
This product is used to quantitatively detect aminomethylfolate (methotrexate) in human serum and plasma by chemical cold light particle immunoassay (CMIA) on the Alinity i analyzer. The measurements obtained are used to monitor aminomethylfolate concentrations to ensure appropriate treatment.
A Clinical chemistry and clinical toxicology
A.1660 Quality control materials (analytical and non-analytical); A.1150 calibration
Input;; Contract manufacturing
Dates and Status
Jan 10, 2020
Jan 10, 2030

